Health & Environmental Research Online (HERO)


Print Feedback Export to File
4188560 
Journal Article 
Review 
Raxibacumab 
Mazumdar, S 
2009 
1 
mAbs
ISSN: 1942-0862 
1 
6 
531-538 
English 
20068396 
WOS:000275224000002 
Raxibacumab (ABthrax) is a human IgGI monoclonal antibody against Bacillus anthracis protective antigen. HGS is currently providing stockpiles of the agent to the US government for use in the prevention and treatment of inhalation anthrax. As of May 2009, the candidate was undergoing review by the US Food and Drug Administration. The availability of bioterrorism countermeasures has become more important since the September 2001 anthrax attacks, and development of raxibacumab is a significant advance in this area. 
raxibacumab; monoclonal antibody; anthrax; anti-PA; animal rule; bioterrorism 
• Inorganic Mercury Salts (2)
     Mercuric Sulfide
          Litsearch 1999-2018